{"schema_version":"secwatch.filing_event.v1","accession":"0001803599-25-000011","form_type":"8-K","ticker":"CNXC","cik":"0001803599","company_name":"Concentrix Corp","filed_at":"2025-01-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.936212+00:00","generated_at":"2026-05-28T01:16:20.634196+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Concentrix Q4 rev $2.45B (+9.7% YoY); GAAP EPS $1.72; buyback auth raised to $600M","bullets":["Q4 revenue $2,448M (+9.7% YoY); FY2024 revenue $9,619M (+35.2% YoY, includes acquisitions).","GAAP operating margin 5.9% (down 220bps); Non-GAAP op margin 14.2% (down 110bps) on GenAI investments.","GAAP diluted EPS $1.72 vs $1.09; Non-GAAP diluted EPS $3.26 vs $3.36.","Adjusted EBITDA Q4 $402.9M (16.5% margin); FY adjusted free cash flow $474.5M.","Quarterly dividend $0.33275/sh payable Feb 11; share repurchase authorization increased to $600M."],"urls":{"canonical":"https://secwatch.observer/filing/0001803599-25-000011","json":"https://secwatch.observer/filing/0001803599-25-000011.json","markdown":"https://secwatch.observer/filing/0001803599-25-000011.md","text":"https://secwatch.observer/filing/0001803599-25-000011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1803599/000180359925000011/0001803599-25-000011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1803599/000180359925000011/cnxc-20250115.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T01:16:20.634196+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}